Bicycle Therapeutics plc (BCYC) Social Stream
BICYCLE THERAPEUTICS PLC (BCYC) Price Targets From Analysts
Use the tables below to see what analysts covering BICYCLE THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 9 | $100 | $40 | $71.222 | $17.46 | 307.92% |
| 2021-12-09 | 11 | $100 | $40 | $72.6 | $17.46 | 315.81% |
| 2022-02-04 | 12 | $100 | $40 | $72.363 | $17.46 | 314.45% |
| 2022-03-02 | 12 | $100 | $40 | $71.333 | $17.46 | 308.55% |
| 2022-03-09 | 12 | $85 | $40 | $67.818 | $17.46 | 288.42% |
| 2022-04-01 | 12 | $100.001 | $40 | $70.5 | $17.46 | 303.78% |
| 2022-04-12 | 12 | $85 | $40 | $68.833 | $17.46 | 294.23% |
| 2022-04-13 | 12 | $85 | $33 | $66.416 | $17.46 | 280.39% |
| 2022-05-06 | 11 | $85 | $33 | $66.416 | $17.46 | 280.39% |
| 2022-05-10 | 11 | $85 | $33 | $65.083 | $17.46 | 272.75% |
| 2022-05-23 | 11 | $85 | $33 | $61.833 | $17.46 | 254.14% |
| 2022-07-12 | 10 | $85 | $33 | $63.5 | $17.46 | 263.69% |
| 2022-07-28 | 11 | $85 | $30 | $60.923 | $17.46 | 248.93% |
| 2022-08-05 | 12 | $85 | $30 | $60.923 | $17.46 | 248.93% |
| 2022-08-06 | 12 | $85 | $30 | $57.692 | $17.46 | 230.42% |
| 2022-08-22 | 12 | $85 | $30 | $57.846 | $17.46 | 231.31% |
| 2022-09-12 | 12 | $85 | $30 | $55.25 | $17.46 | 216.44% |
| 2022-11-06 | 13 | $75 | $30 | $52.545 | $17.46 | 200.95% |
| 2022-11-10 | 14 | $75 | $30 | $52.916 | $17.46 | 203.07% |
| 2023-01-05 | 15 | $75 | $30 | $54.571 | $17.46 | 212.55% |
| 2023-02-08 | 13 | $75 | $30 | $53.769 | $17.46 | 207.96% |
| 2023-02-28 | 13 | $75 | $30 | $53.769 | $17.46 | 207.96% |
| 2023-03-01 | 14 | $75 | $30 | $53.769 | $17.46 | 207.96% |
| 2023-04-12 | 14 | $72 | $30 | $52.076 | $17.46 | 198.26% |
| 2023-04-19 | 13 | $72 | $30 | $52.076 | $17.46 | 198.26% |
| 2023-05-05 | 14 | $72 | $30 | $52 | $17.46 | 197.82% |
| 2023-06-27 | 14 | $72 | $30 | $51.769 | $17.46 | 196.5% |
| 2023-08-04 | 13 | $72 | $33 | $53 | $17.46 | 203.55% |
| 2023-08-06 | 13 | $65 | $33 | $49 | $17.46 | 180.64% |
| 2023-11-03 | 13 | $65 | $33 | $49 | $17.46 | 180.64% |
| 2023-11-06 | 13 | $65 | $33 | $48.818 | $17.46 | 179.6% |
| 2023-11-15 | 13 | $59 | $33 | $47.2 | $17.46 | 170.33% |
| 2023-12-14 | 11 | $59 | $33 | $45.25 | $17.46 | 159.16% |
| 2023-12-19 | 11 | $59 | $30 | $43.625 | $17.46 | 149.86% |
| 2023-12-20 | 11 | $59 | $30 | $42.125 | $17.46 | 141.27% |
| 2023-12-22 | 12 | $60 | $30 | $44.111 | $17.46 | 152.64% |
The Trend in the Analyst Price Target
Over the past 33 weeks, BCYC's average price target has gone down $7.89.
BCYC reports an average of 138.27% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-27 | 14 | 72 | 30 | 51.769 | 24.38 | 112.34% |
| 2023-08-06 | 13 | 72 | 33 | 51.909 | 23.47 | 121.17% |
| 2023-11-15 | 13 | 59 | 33 | 46.888 | 15.39 | 204.67% |
| 2023-11-15 | 12 | 59 | 33 | 47.200 | 15.39 | 206.69% |
| 2023-12-20 | 11 | 59 | 30 | 42.125 | 18.08 | 132.99% |
BCYC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 10 | 1 | 1 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BCYC's average broker recommendation rating improved by 0.04.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BICYCLE THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is greater than 4152.92% of them.
- In terms of how BICYCLE THERAPEUTICS PLC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3703.12% of that group.
- BICYCLE THERAPEUTICS PLC's number of analysts covering the stock is greater than 4651.22% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, BICYCLE THERAPEUTICS PLC's average analyst price target is higher than 4382.11% of them.
In the Pharmaceutical Products industry, CELU, APLT, and NXTC are the three stocks most similar to BICYCLE THERAPEUTICS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for BCYC? Use POWR Ratings for clearer insight into price direction.